Expressed sequence tags (ESTs) and single nucleotide polymorphisms (SNPs): What large-scale sequencing projects can tell us about ADME

Xenobiotica

Volumn 36, Issue 10-11, 2006, Pages 860-876

  Plant, N ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Expressed sequence tag; Phylogenetic analysis; Single nucleotide polymorphism (SNP); Species difference

Indexed keywords

ABACAVIR; AZATHIOPRINE; CAFFEINE; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; EPOTHILONE A; IRINOTECAN; ISONIAZID; MESSENGER RNA; NELFINAVIR; OMEPRAZOLE; PACLITAXEL; PRAVASTATIN; PREGNANE X RECEPTOR; PSYCHOTROPIC AGENT; REPAGLINIDE; RIFAMPICIN; TSUKUBAENOLIDE; WARFARIN;

ALTERNATIVE RNA SPLICING; COLORECTAL CANCER; DNA BINDING; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEAD CANCER; HUMAN; HYPERANDROGENISM; ISCHEMIC HEART DISEASE; MOOD DISORDER; NECK CANCER; NONHUMAN; PHYLOGENY; PROSTATE CANCER; PROTEIN INDUCTION; REVIEW; RNA SPLICING; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE;

ALTERNATIVE SPLICING; ANIMALS; EXPRESSED SEQUENCE TAGS; HUMANS; METABOLISM; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 33751576159     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250600861603     Document Type: Review

References (84)

1. Ando M, Hasegawa Y, Ando Y. 2005. Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan. Investigations on New Drugs 23:539-545.
2. Aouabdi S, Gibson GG, Plant N. 2006. Transcriptional regulation of PXR: Identification of a PPRE within the proximal promoter responsible for fibrate-mediated transcriptional activation of PXR. Drug Metabolism and Disposition 34:138-144.
3. Bateman A, Coin L, Durbin R, Finn RD, Hollich V, Griffiths-Jones S, Khanna A, Marshall M, Moxon S, Sonnhammer EL, Studholme DJ, Yeats C, Eddy SR. 2004. The Pfam protein families database. Nucleic Acids Research 32:138-141.
4. Bavner A, Sanyal S, Gustafsson JA, Treuter E. 2005. Transcriptional corepression by SHP: Molecular mechanisms and physiological consequences. Trends in Endocrinology and Metabolism 16:478-488.
5. Bertilsson L, Dahl ML, Dalen P, Al-Shurbaji A. 2002. Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs. British Journal of Clinical Pharmacology 53:111-122.
6. Birney E, Andrews TD, Bevan P, Caccamo M, Chen Y, Clarke L, Coates G, Cuff J, Curwen V, Cutts T, et al. 2004. An overview of Ensembl. Genome Research 14:925-926.
7. Birney E, Durbin R. 2000. Using GeneWize in the Drosophila annotation experiment. Genome Research 10:547-548.
8. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D, Luo S, McCurdy S, Foy M, Ewan M, et al. 2000. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nature Biotechnology 18:630-634.
9. Burset M, Seledtsov IA, Solovyev VV. 2001. SpliceDB: Database of canonical and non-canonical mammalian splice sites. Nucleic Acids Research 29:255-259.
10. Butcher NJ, Arulpragasam A, Goh HL, Davey T, Minchin RF. 2005. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translations activities. Biochemical Journal 387:119-127.
11. Chantry-Darmon C, Urien C, Hayes H, Bertaud M, Chadi-Taourit S, Chardon P, Vaiman D, Rogel-Gaillard C. 2005. Construction of a cytogenetically anchored microsatellite map in rabbit. Mammalian Genome 16:442-459.
12. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, et al. 1996. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders. Molecular Psychiatry 1:453-460.
13. Dai Y, Hebert MF, Isoherranen N, Davis CL, Marsh C, Shen DD, Thummel KE. 2006. Effect of cyp3a5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metabolism and Disposition 34:836-847.
14. Doddapaneni H, Chakraborty R, Yadav JS. 2005. Genome-wide structural and evolutionary analysis of the P450 monooxygenase genes (P450ome) in the white rot fungus Phanerochaete chrysosporium: Evidence for gene duplications and extensive gene clustering. BMC Genomics 6:92.
15. Donald PR, Sirgel FA, Venter A, Parkin DP, Seifart HI, Van de Wal BW, Werely C, Van Helden PD, Maritz JS. 2004. The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clinical Infection and Disease 39:1425-1430.
16. Feinberg AP, Cui H, Ohlsson R. 2002. DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms. Seminars in Cancer Biology 12:389-398.
17. Fredman D, Siegfried M, Yuan YP, Bork P, Lehvaslaiho H, Brookes AJ. 2002. HGVBase: A human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Research 30:387-391.
18. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. 2004. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. Journal of Clinical Investigation 114:1343-1353.
19. Furuta T, Shirai N, Sugimoto M, Nakamura A, Hishida A, Ishizaki T. 2005. Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metabolism and Pharmacokinetics 20:153-167.
20. Gawronska-Szklarz B, Lubinski J, Kladny J, Kurzawski G, Bielicki D, Wojcicki M, Sych Z, Musial HD. 1999. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Experimental and Toxicologic Pharmacology 51:321-325.
21. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, et al. 2004. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428:493-521.
22. Gibson G, Plant N, Swales K, Ayrton A, El-Sankary W. 2002. Receptor-dependent transcriptional activation of cytochrome P450 3A genes: Induction mechanisms, species differences and inter-individual variation in man. Xenobiotica 32:165-206.
23. Gooderham NJ, Murray S, Lynch AM, Yadollahi-Farsani M, Zhao K, Boobis AR, Davies DS. 2001. Food-derived heterocyclic amine mutagens: Variable metabolism and significance to humans. Drug Metabolism and Disposition 29:529-534.
24. Guo W, Burris TP, Zhang YH, Huang BL, Mason J, Copeland KC, Kupfer SR, Pagon RA, McCabe ER. 1996. Genomic sequence of the DAX1 gene: An orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 81:2481-2486.
25. Handschin C, Podvinec M, Meyer U. (2000). CXR, a chicken xenobiotic-sensing orphan nuclear receptor is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proceedings of the National Academy of Sciences, USA 97: 10769-10774.
26. Hanke J, Brett D, Zastrow I, Aydin A, Delbruck S, Lehmann G, Luft F, Reich J, Bork P. 1999. Alternative Splicing of human genes: More the rule than the exception?. Trends in Genetics 15:389-390.
27. Horie-Inoue K, Takayama K, Bono HU, Ouchi Y, Okazaki Y, Inoue S. 2006. Identification of novel steroid target genes through the combination of bioinformatics and functional analysis of hormone response elements. Biochemical and Biophysical Research Communications 339:99-106.
28. Huang HD, Horng JT, Lee CC, Liu BJ. 2003. ProSplicer: A database of putative alternative splicing information derived from protein, mRNA and expressed sequence tag sequence data. Genome Biology 4:R29.
29. Hughes DA, Vilar FJ, Ward CC, Alfirevic A, Park BK, Pirmohamed M. 2004. Cost-effectiveness analysis of HLA B5701 genotyping in preventing abacavir hypersensitivity. Pharmacogenetics 14:335-342.
30. Human Genome Consortium. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-945.
31. International HapMap Consortium. 2003. The International HapMap project. Nature 426:789-796.
32. International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437:1299-1320.
33. Jongeneel CV, Delorenzi M, Iseli C, Zhou D, Haudenschild CD, Khrebtukova I, Kuznetsov D, Stevenson BJ, Strausberg RL, Simpson AJ, et al. 2005. An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Research 15:1007-1014.
34. Jun JB, Cho DY, Kang C, Bae SC. 2005. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine. Clinical and Experimental Rheumatology 23:873-976.
35. Kirchheiner J, Brockmoller J. 2005. Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology and Therapeutics 77:1-16.
36. Kuehl P, Zhang J, Lin Y, Lanba J, Assem M, Scheutz J, Watkins P, Daly A, Wrighton S, Hall S, et al. 2001. Sequence diversity in CYP3A promoters and characterisation of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics 27:383-391.
37. Kumar S, Hedges SB. 1998. A molecular timescale for vertebrate evolution. Nature 392:917-920.
38. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
39. Lareau LF, Green RE, Bhatnagar RS, Brenner SE. 2004. The evolving roles of alternative splicing. Current Opinion in Structural Biology 14:273-282.
40. Lee C, Atanelov L, Modrek B, Xing Y. 2003. ASAP: The Alternative Splicing Annotation Project. Nucleic Acids Research 31:101-105.
41. Lim YP, Liu CH, Shyu LJ, Huang JD. 2005. Functional characterization of a novel polymorphism of pregnane X receptor, Q158K, in Chinese subjects. Pharmacogenetics and Genomics 15:337-341.
42. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ 3rd, Zody MC, et al. 2005. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803-819.
43. Loots GG, Ovcharenko I. 2004. rVISTA 2.0: Evolutionary analysis of transcription factor binding sites. Nucleic Acids Research 32:W217-W221.
44. Loots GG, Ovcharenko I, Pachter L, Dubchak I, Rubin EM. 2002. rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Research 12:832-839.
45. Mandel S, Weinreb O, Youdim MB. 2003. Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. Trends in Pharmacological Sciences 24:184-191.
46. Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, Augenlicht LH. 2002. A gene expression profile that defines colon cell maturation in vitro. Cancer Research 62:4791-4804.
47. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, Katoh T, Kamataki T, Kawamura J, Yatani R, et al. 2001. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Letters 165:171-177.
48. Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, Dunlea S, Eynon BP, Pearson CI, Tugendreich S, Jarnagin K. 2005. Classification of a large microarray data set: Algorithm comparison and analysis of drug signatures. Genome Research 15:724-736.
49. Nebert DW, Gonzalez FJ. 1987. P450 genes: Structure, evolution, and regulation. Annual Review of Biochemistry 56:945-993.
50. Nelson DR. 2002. Mining databases for cytochrome P450 genes. Methods in Enzymology 357:3-15.
51. Nelson DR. 2003. Comparison of P450s from human and fugu: 420 million years of vertebrate P450 evolution. Archives of Biochemistry and Biophysics 409:18-24.
52. Nelson DR. 2005. Gene nomenclature by default, or BLASTing to Babel. Human Genomics 2:196-201.
53. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereizen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. 1996. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
54. Nelson DR, Schuler MA, Paquette SM, Werck-Reichhart D, Bak S. 2004. Comparative genomics of rice and Arabidopsis. Analysis of 727 cytochrome P450 genes and pseudogenes from a monocot and a dicot. Plant Physiology 135:756-772.
55. Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Brode P, Vetter H, Bolt HM, Pesch B, Bruning T. 2004. Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicology Letters 151:273-282.
56. Niakan KK, McCabe ER. 2005. DAX1 origin, function, and novel role. Molecular Genetics and Metabolism 86:70-83.
57. Niemi M, Backman JT, Kajosaari LI, Leathart JB, Neuvonen M, Daly AK, Eichelbaum M, Kivisto KT, Neuvonen PJ. 2005. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clinical Pharmacology and Therapeutics 77:468-478.
58. Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman JT, Kerb R, Schwab M, Neuvonen PJ, et al. 2004. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14:429-440.
59. Ozyildirim AM, Wistow GJ, Gao J, Wang J, Dickinson DP, Frierson Jr. HF, Laurie GW. 2005. The lacrimal gland transcriptome is an unusually rich source of rare and poorly characterized gene transcripts. Investigations in Ophthalmology and Visual Science 46:1572-1580.
60. Pennacchio LA, Rubin EM. 2003. Comparative genomic tools and database: Providing insights into the human genome. Journal of Clinical Investigation 111:1099-1106.
61. Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH, de Zegher F, Ibanez L, Dunger DB. 2005. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women. Human Reprodroduction 20:1837-1843.
62. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Malkowicz SB. 1998. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. Journal of the National Cancer Institute 90:1225-1229.
63. Rogler CE, Tchaikovskaya T, Norel R, Massimi A, Plescia C, Rubashevsky E, Siebert P, Rogler LE. 2004. RNA expression microarrays (REMs), a high-throughput method to measure differences in gene expression in diverse biological samples. Nucleic Acids Research 32:e120.
64. Sachse C, Brochmoller J, Bauer S, Roots I. 1999. Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine. British Journal of Clinical Pharmacology 47:445-449.
65. Saitoh A, Singh KK, Powell CA, Fenton T, Fletcher CV, Brundage R, Starr S, Spector SA. 2005. An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children. AIDS 19:371-380.
66. Schwartz S, Zhang Z, Frazer KA, Smit A, Riemer C, Bouck J, Gibbs R, Hardison R, Miller W. 2000. PipMaker - a web server for aligning two genomic DNA sequences. Genome Research 10:577-586.
67. Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI. 1997. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proceedings of the National Academy of Sciences. USA 94:4615-4619.
68. Sherry ST, Ward M, Sirotkin K. 1999. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Research 9:677-679.
69. Song X, Xie M, Zhang H, Li Y, Sachdeva K, Yan B. 2004. The pregnane X receptor binds to response elements in a genomic context-dependent manner, and PXR activator rifampicin selectively alters the binding among target genes. Drug Metabolism and Disposition 32:35-42.
70. Spiecker M, Darius H, Hankeln T, Soufi M, Sattler AM, Schaefer JR, Node K, Borgel J, Mugge A, Lindpaintner K, et al. 2004. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation 110:2132-2136, Epub 4 October 2004.
71. Steketee K, Ziel-van der Made AC, Van der Korput HA, Houtsmuller AB, Trapman J. 2004. A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron. Journal of Molecular Endocrinology 33:477-491.
72. Thanaraj TA, Stamm S, Clark F, Riethoven JJ, Le Texier V, Muilu J. 2004. ASD: The Alternative Splicing Database. Nucleic Acids Research 32:D64-D69.
73. Thorisson GA, Stein LD. 2003. The SNP Consortium website: Past, present and future. Nucleic Acids Research 31:124-127.
74. Tukey RH, Strassburg CP. 2000. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annual Reviews in Pharmacology and Toxicology 40:581-616.
75. Vizirianakis IS. 2004. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice. Current Drug Delivery 1:73-80.
76. Wang Y, O'Brate A, Zhou W, Giannakakou P. 2005. Resistance to microtubule-stabilizing drugs involves two events: Beta-tubulin mutation in one allele followed by loss of the second allele. Cell Cycle 4:1847-1853.
77. Wang Z, Chen Y, Li Y. 2004. A brief review of computational gene prediction methods. Genomics. Proteomics and Bioinformatics 2:216-221.
78. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
79. Werck-Reichhart D, Feyereizen R., (2000). Cytochromes P450: A success story. Genome Biology 1: REVIEWS3003; Epub 8 December 2000.
80. Wren JD, Forgacs E, Fondon JW 3rd, Pertsemlidis A, Cheng S, Gallardo T, Williams RS, Shohet RV, Minna JD, Garner HR. 2000. Repeat polymorphisms within gene regions: Phenotypic and evolutionary implications. American Journal of Human Genetics 67:345-356.
81. Xie W, Barwick JL, Simmon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, Evans RM. 2000. Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes and Development 14:3014-3023.
82. Xing Y, Xu Q, Lee C. 2003. Widespread production of novel soluble protein isoforms by alternative splicing removal of transmembrane anchoring domains. FEBS Letters 555:572-578.
83. Zhang H, Ahmadi A, Arbman G, Zdolsek J, Carstensen J, Nordenskjold B, Soderkvist P, Sun XF. 1999. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. International Journal of Cancer 84:135-138.
84. Zhang Z, Burch PE, Cooney AJ, Lanz RB, Pereira FA, Wu J, Gibbs RA, Weinstock G, Wheeler DA. 2004. Genomic analysis of the nuclear receptor family: New insights into structure, regulation, and evolution from the rat genome. Genome Research 14:580-590.